Affordable Access

Publisher Website

Chemical makeover inhibits IL-8

Journal of Experimental Medicine
The Rockefeller University Press
Publication Date
DOI: 10.1084/jem.2059iti4
  • In This Issue
  • Biology


untitled IN THIS ISSUE | The Journal of Experimental Medicine 1945 Text by Hema Bashyam [email protected] Chemical makeover inhibits IL-8 On page 2085, Proost et al. find that altering a single arginine turns an inflammatory chemokine docile. The chemokine IL-8, which activates and recruits neutrophils, is secreted as a mixture of isoforms that vary in length due to proteolysis. A cut after the first five amino end residues produces active protein, whereas cuts elsewhere inhibit activity. Proteolysis might thus be one way to control the amount of active IL-8, but it’s not the only one, as Proost et al. now find. The transformation of a single arginine into the nonessential amino acid citrulline also shuts it down. Among the IL-8 isoforms secreted by activated human immune cells, one lacked the arginine adjacent to the activating cleavage site. The lack of mutations in this isoform suggested that the alteration was post-translational, and the protein had not been trimmed, suggesting that the arginine had been replaced rather than cleaved off. The alteration did not change the isoform’s mass, hinting that the replacement residue might be citrulline, which is similar in mass to arginine. Indeed, the authors found citrulline in arginine’s place. Citrulline-containing IL-8 did not efficiently activate the IL-8 receptor on neutrophils, as it resisted the activating proteolysis. It also bound poorly to sugar groups that help tether neutrophils to blood vessels. When injected into mice, this isoform thus failed to draw neutrophils to the injection site. This modified isoform accounted for only a small fraction of the total IL-8 produced by activated cells in culture. Whether cells produce more of this isoform in vivo is not yet known. The authors have also yet to determine whether the isoform’s production increases during inflammation. The enzyme that turns arginine into citrulline, peptidylarginine deiminase (PAD), is secreted mostly by monocytes, which follow ne

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Cyclosporin-A inhibits IL-2 production by all huma...

on Clinical Immunology and Immuno... Jan 01, 1986

OKT8 antibody inhibits OKT3-induced IL 2 productio...

on The Journal of Immunology November 1983

IL-15 inhibits IL-7Rα expression by memory-phenoty...

on European Journal of Immunology May 2012
More articles like this..